SCIENTIFIC PROGRAM
| THURSDAY, JUNE 25, 2026 | ||
| 08:00 – 09:00 | Registration | |
| 09:00 – 09:15 | Opening Ceremony | |
| 09:15 – 09:45 | Opening Lecture Chairs: Michael Schirmer, Andreas Altenburg, Ahmet Gül |
|
| Hulusi Behçet and His Legacy | ||
| 09:45 – 11:05 | Basic Sciense: What is New? Chairs: Güher Saruhan Direskeneli, Jan van Laar, Graham Wallace |
|
| 09:45 – 10:05 | HLA and Behçet Disease – What is New? | Johannes Nowatzky |
| 10:05 – 10:25 | Single Cell Studies in Behçet Disease | Amr Sawalha |
| 10:25 – 10:45 | Update on the Animal Models | Seonghyang Sohn |
| 10:45 – 11:05 | Overview and Discussion | Martin van Hagen |
| 11:05 – 11:25 | Oral Presentations | |
| 11:25 – 11:45 | COFFEE BREAK | |
| 11:45 – 12:35 | Conference Chairs: Eun-So Lee, Vedat Hamuryudan |
|
| 11:45 – 12:05 | Behçet Disease Around the Globe | Farhad Shahram |
| 12:05 – 12:25 | Changes in the Disease Phenotpe | Yohei Kirino |
| 12:25 – 12:35 | Discussion | |
| 12:35 – 13:30 | LUNCH BREAK AND POSTER VIEWING | |
| 13:30 – 15:20 | Mucocutaneous Involvement Chairs: Dongsik Bang, Tülin Ergun, Ayşe Boyvat |
|
| 13:30 – 13:50 | Bipolar Aphthosis | Erkan Alpsoy |
| 13:50 – 14:10 | Non-Aphthous Mucocutaneous Findings | Doyoung Kim |
| 14:10 – 14:30 | Pathergy Phenomenon | Ahmet Gül |
| 14:30 – 14:50 | What is the Ideal Treatment for Individual Patient? | Tülin Ergun |
| 14:50 – 15:10 | How to Monitor Oral Disease Activity? | Gonca Mumcu |
| 15:10 – 15:20 | Discussion | |
| 15:20 – 15:40 | Oral Presentations | |
| 15:40 – 16:00 | COFFEE BREAK | |
| 16:00 – 17:10 | Pediatric Behçet Disease and Differential Diagnosis Chairs: I. Kone-Paut, Nuray Aktay Ayaz, Özgür Kasapçopur |
|
| 16:00 – 16:20 | Pediatric Behçet Disease: Summary of the Task Force Works | Seza Özen |
| 16:20 – 16:40 | Monogenic Mimics of Behçet Disease | Fatma Dedoğlu (Online) |
| 16:40 – 17:00 | Trisomy 8, Myelodysplastic Syndrome and TRIAD | Kalpana Manthiram (Online) |
| 17:00 – 17:10 | Discussion | |
| 17:10 – 18:20 | Clinical Trial Designs – Round Table Chairs: Gülen Hatemi, Robert Moots |
|
| Challenges and Pitfalls of Clinical Trials | Gülen Hatemi | |
| Problems in Study Design Individual Manifestations (Round Table) | ||
| Vascular Involvement | David Saadoun | |
| Ocular Involvement | Bahram Bodaghi | |
| Gastrointestinal Involvement | İbrahim Hatemi | |
| Mucocutaneous Involvement | Farida Fortune | |
| Musculoskeletal Involvement | Ina Kötter | |
| Assessment of Damage | Luca Cantarini | |
| Wrap-Up | Robert Moots | |
| 18:20 – 18:30 | Wrap-Up and Final Discussion of the First Day | |
| FRIDAY, JUNE 26, 2026 | ||
| 08:00 – 09:00 | Study Group Meetings | |
| 09:00 – 09:30 | Colin Barnes Conference Chairs: Vedat Hamuryudan, Robert Moots |
|
| Colin Barnes and His Contributions to the Research in Behçet Disease | Hasan Yazıcı | |
| 09:30 – 10:40 | Criteria for Classification and Diagnosis Chairs: Hasan Yazıcı, Michael Schirmer |
|
| 09:30 – 09:50 | Pitfalls of the Criteria in the Diagnostic Algorithms | Christos Zoubulis |
| 09:50 – 10:10 | HLA-B51 and Other Tools in the Assessment of Disease Activity, Severity and Prognosis |
Mitsuhiro Takeno |
| 10:10 – 10:30 | How to Improve the Criteria for Neuro-Behçet Disease? | Aksel Siva |
| 10:30 – 10:40 | Discussion | |
| 10:40 – 11:00 | COFFEE BREAK | |
| 11:00 – 12:00 | Ocular Involvement – Differential Diagnosis and Monitoring Masaki Takeuchi Conference Chair: Yohei Kirino, Pınar Özdal |
|
| 11:00 – 11:10 | Introduction | Yohei Kirino |
| 11:10 – 11:40 | Distinctive Features of Behçet Disease Uveitis and Differential Diagnosis | İlknur Tuğal Tutkun |
| 11:40 – 11:45 | Discussion | |
| 11:45 – 12:00 | Oral Presentations | |
| 12:00 – 13:00 | LUNCH BREAK AND POSTER VIEWING | |
| 13:00 – 14:30 | Ocular – Disease Monitoring and Treatment Chairs: İlknur Tuğal Tutkun, İzzet Fresko |
|
| 13:00 – 13:20 | Monitoring Tools for Non-Ophthalmologists | Hilal Eser Öztürk |
| 13:20 – 13:45 | Anti-TNF and Alternative Treatments in Behçet Disease Uveitis | Didar Uçar |
| 13:45 – 14:15 | How to Define Remission and Discontinue Treatment | Pınar Özdal |
| 14:15 – 14:30 | Discussion | Panel |
| 14:30 – 15:00 | Oral Presentations | |
| 15:00 – 15:20 | COFFEE BREAK | |
| 15:20 – 15:50 | Gastrointestinal Involvement – Round Table | |
| Intestinal Inflammation as a Model of Complex Disease | Aykut Ferhat Çelik, Ahmet Gül | |
| 15:50 – 16:40 | Differential Diagnosis Chairs: Murat Törüner, Aykut Ferhat Çelik |
|
| 15:50 – 16:10 | Differential Diagnosis with IBD (Turkish experience) | Aykut Ferhat Çelik |
| 16:10 – 16:30 | Differential Diagnosis with IBD (Korean experience) | Jae Hee Cheon (Online) |
| 16:30 – 16:40 | Discussion | |
| 16:40 – 17:10 | Oral Presentations | |
| 17:10 – 17:30 | COFFEE BREAK | |
| 17:30 – 18:45 | Inflammatory Pathways and Targeted Treatments Chairs: Murat İnanç |
|
| 17:30 – 17:45 | Biologic Treatments in Spondyloarthritis | Abdurrahman Tufan |
| 17:45 – 18:00 | Colchicine Resistance and Biologic Treatments in FMF and Other SAIDs | Serdal Uğurlu |
| 18:00 – 18:15 | Biologic Treatment Targets in Non-Infectious Uveitis | Nilüfer Yalçındağ |
| 18:15 – 18:30 | Targeted Treatments in Inflammatory Bowel Disease | Murat Törüner |
| 18:30 – 18:45 | How to Extrapolate to BD: Targeted and Personalized Treatment Strategies | Yohei Kirino |
| 18:45 – 18:50 | Wrap-Up and Discussion | |
| 18:50 – 19:50 | ISBD Meeting | |
| SATURDAY, JUNE 27, 2026 | ||
| 08:00 – 09:00 | Study Group Meetings | |
| 09:00 – 10:30 | Cardiovascular Involvement Chairs: David Saadoun, Melike Melikoğlu |
|
| 09:00 – 09:20 | Pulmonary Involvement – More Than Thought | Fatma Alibaz |
| 09:20 – 09:40 | Coronary and Cardiac Involvement | Emire Seyahi |
| 09:40 – 10:00 | Is Behçet Disease a Thromboinflammatory Venulitis? | Giacomo Emmi |
| 10:00 – 10:20 | Screening of the Patients for CV Involvement | Panel |
| 10:20 – 10:30 | Discussion | |
| 10:30 – 10:40 | Oral Presentations | |
| 10:40 – 11:00 | COFFEE BREAK | |
| 11:00 – 11:50 | Neurologic – Differential Diagnosis and Monitoring Chairs: Gülşen Akman Demir, Aksel Siva |
|
| 11:00 – 11:20 | Atypical Presentations of Neuro-BD | Tuncay Gündüz |
| 11:20 – 11:40 | How to Monitor and Treat Neuro-BD? | Uğur Uygunoğlu |
| 11:40 – 11:50 | Discussion | |
| 11:50 – 12:00 | Oral Presentation | |
| 12:00 – 13:00 | LUNCH BREAK AND POSTER VIEWING | |
| 13:00 – 13:30 | Oral Presentations | |
| 13:30 – 14:30 | Recent Recommendations for Management Chairs: Sabahattin Yurdakul, Giacomo Emmi |
|
| 13:30 – 13:55 | Updated EULAR Recommendations | Gülen Hatemi |
| 13:55 – 14:20 | Other Recommendations for the Management of BD | Haner Direskeneli |
| 14:20 – 14:30 | Discussion | |
| 14:30 – 14:50 | COFFEE BREAK | |
| 14:50 – 15:45 | Personalized Medicine and Expectations for the Future Chairs: Tazi Mezalek Zoubida, Farida Fortune |
|
| 14:50 – 15:10 | Patient Perspective | Rosaria Talarico |
| 15:10 – 15:30 | Drug-Free Remission: A Realistic Target? | Nikolaos Kougkas |
| 15:30 – 15:45 | International Collaborations | Alessandra Bettiol |
| 15:45 – 16:00 | Wrap-Up and Discussion | |
| 16:00 | Adjourn | |
